Skip to main content
. Author manuscript; available in PMC: 2022 Jan 21.
Published in final edited form as: J Neurovirol. 2021 Mar 2;27(2):228–238. doi: 10.1007/s13365-020-00933-1

Table 1.

Participants’ socio-demographical and clinical characteristics

Variables All participants (n = 129) HIV+ (n = 94) HIV− (n = 35) p valuea
Gender (M/F) 107:22 84:10 23:12 < 0.01
Race (W/NW) 65:64 48:46 17:18 0.06
Age 54 (48–62) 53.5 (49, 61) 55 (46.5, 67.5) 0.45
Education 14 (12–16) 14 (12, 16) 14 (12, 16) 0.90
LT MDD (Y/N)b 66:61 56:36 10:25 < 0.01
LT SUD (Y/N)b 89:38 73:19 16:19 < 0.01
EDI (years) - 20.2 (12.7, 26.4) - -
Nadir CD4 (cells/μL) - 123 (18.8, 324.3) - -
CD4 absolute (cells/μL) - 612 (430, 792) - -
CD4 percent (%) - 25.8 (32.1, 40.3) - -
CD8 absolute (cells/μL) - 797 (545.5, 1102) - -
CD8 percent (%) - 41.7 (34.5, 53.4) - -
CD4 CD8 ratio - 0.76 (0.49, 1.18) - -
% on ART - 95% - -
% RNA levels undetectable - 90% - -

Characteristics of all of our participants

M male, F female, W White, NW not White, LT MDD lifetime major depression disorder diagnosis, LT SUD lifetime substance use disorder diagnosis, EDI estimated duration of infection

a

The p value of a double tailed chi-squared or Mann-Whitney test. There was a significant association between biological sex, LT MDD, LT SUD, and HIV status in relation to HIV serostatus

b

Missing data of 2 participants in the LT MDD and LT SUD variables that did not underwent structured interviews to asses LT MDD and LT SUD